Immutep Receives Nasdaq Notice of Bid Price Deficiency
Market Intelligence Analysis
AI-PoweredFinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Article Context
SYDNEY, AUSTRALIA, April 30, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), advises that it has received a written notification from The Nasdaq Stock Market LLC (Nasdaq) regarding non-compliance with the Nasdaq minimum bid price requirement. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of US$1.00 per share. Based on the closing bid price of the Company’s American Depositary Shares for the 30 consecutive
AI Breakdown
Summary
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Time Horizon
Short Term
Analysis and insights provided by AnalystMarkets AI.